Beswick Daniel M, Santa Maria Chloe, Ayoub Noel F, Capasso Robson, Santa Maria Peter Luke
Department of Otolaryngology, Head and Neck Surgery, Stanford University, Palo Alto, CA, USA.
Ear Sciences Centre, The University of Western Australia, Nedlands, Australia.
Eur Arch Otorhinolaryngol. 2018 Feb;275(2):569-578. doi: 10.1007/s00405-017-4810-6. Epub 2017 Nov 29.
To provide histological evidence to investigate a theory for post-tonsillectomy secondary hemorrhage (PTH) in a mouse model and to evaluate the potential for heparin-binding epidermal growth factor-like growth factor (HB-EGF) treatment on wound healing in this model.
A prospective randomized single-blinded cohort study. A uniform tongue wound was created in 84 mice (day 0). Mice were randomized to HB-EGF (treatment, n = 42) or saline (control, n = 42). In treatment mice, HB-EGF 5 µg/ml was administered intramuscularly into the wound daily (days 0-14). In control mice, normal saline was administered daily. Three mice from each group were sacrificed daily through day 14 and the wounds evaluated histologically by blinded reviewers.
Key stages of wound healing, including keratinocyte proliferation and migration, wound contraction, epithelial separation, and neoangiogenesis, are defined with implications for post-tonsillectomy wound healing. Epithelial separation (59 vs. 100%, p = 0.003) and wound reopening (8 vs. 48%, p < 0.001) were reduced with HB-EGF. Epithelial thickness (220 vs. 30 µm, p = 0.04) was greater with HB-EGF. Wound closure (days 4-5 vs. day 6, p = 0.01) occurred earlier with HB-EGF.
In healing of oral keratinocytes on muscle epithelial separation secondary to muscle, contraction occurs concurrently with neoangiogenesis in the base of the wound, increasing the risk of hemorrhage. This potentially explains why post-tonsillectomy secondary hemorrhage occurs and its timing. HB-EGF-treated wounds showed greater epithelial thickness, less frequent epithelial separation and wound reopening, and earlier wound closure prior to neovascularization, suggesting that HB-EGF may be a potential preventative therapy for PTH.
NA-animal studies or basic research.
提供组织学证据以研究小鼠模型中扁桃体切除术后继发性出血(PTH)的一种理论,并评估肝素结合表皮生长因子样生长因子(HB-EGF)治疗该模型伤口愈合的潜力。
一项前瞻性随机单盲队列研究。在84只小鼠(第0天)中制造统一的舌部伤口。将小鼠随机分为HB-EGF组(治疗组,n = 42)或生理盐水组(对照组,n = 42)。在治疗组小鼠中,每天(第0 - 14天)将5 μg/ml的HB-EGF肌肉注射到伤口处。在对照组小鼠中,每天注射生理盐水。每组每天处死3只小鼠,直至第14天,由盲法评估者对伤口进行组织学评估。
定义了伤口愈合的关键阶段,包括角质形成细胞增殖和迁移、伤口收缩、上皮分离和新血管形成,这些对扁桃体切除术后伤口愈合具有启示意义。HB-EGF可减少上皮分离(59%对100%,p = 0.003)和伤口裂开(8%对48%,p < 0.001)。HB-EGF组的上皮厚度更大(220μm对30μm,p = 0.04)。HB-EGF可使伤口闭合更早(第4 - 5天对第6天,p = 0.01)。
在肌肉继发的口腔角质形成细胞愈合过程中,上皮分离时,伤口底部的收缩与新血管形成同时发生,增加了出血风险。这可能解释了扁桃体切除术后继发性出血的发生原因及其时间。经HB-EGF治疗的伤口显示上皮厚度更大,上皮分离和伤口裂开的频率更低,并且在新血管形成之前伤口闭合更早,表明HB-EGF可能是PTH的一种潜在预防性治疗方法。
NA - 动物研究或基础研究。